About Hospital Distrital de Faro
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Central European Cooperative Oncology Group
1
Hoffmann-La Roche
1
Clinical Trials at Hospital Distrital de Faro
During the past decade, Hospital Distrital de Faro conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy
2003-04-01
2005-12-01
Completed
885
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
2002-12-01
2004-04-01
Completed
311
Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer
2005-07-01
2007-10-01
Completed
150
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Distrital de Faro"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hospital Distrital de Faro
According to Clinical.Site data, the most researched conditions in "Hospital Distrital de Faro" are
"Breast Cancer" (1 trials), "Diabetic Nephropathies" (1 trials), "Hypertension" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Hospital Distrital de Faro" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Distrital de Faro
Most popular intervention types in "Hospital Distrital de Faro" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan" (1 trials), "FOLFIRI" (1 trials), "FOLFOX 6" (1 trials), "Herceptin" (1 trials) and "Pulmonary function Testing" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Distrital de Faro
The vast majority of trials in "Hospital Distrital de Faro" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital Distrital de Faro
Currently, there are NaN active trials in "Hospital Distrital de Faro".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Distrital de Faro,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Distrital de Faro, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".